December 11, 2017
December 11, 2017 —
Rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs, report University of California San Diego School of Medicine and Moores Cancer Center researchers.
December 11, 2017
December 11, 2017 —
Researchers at University of California San Diego School of Medicine have found a genetic signature for delay discounting — the tendency to undervalue future rewards — that overlaps with attention-deficit/hyperactivity disorder (ADHD), smoking and weight.
December 6, 2017
December 6, 2017 —
Thirty two faculty members at the University of California San Diego are among the world’s most influential researchers in their fields, based on their publications over the past decade.
December 5, 2017
December 5, 2017 —
Using a database of multiple myeloma patient samples and information, researchers at University of California San Diego School of Medicine found that high ADAR1 levels correlate with reduced survival rates. They also determined that blocking the enzyme reduces multiple myeloma regeneration in experimental models derived from patient cancer cells.
December 3, 2017
December 3, 2017 —
Two full-time University of California San Diego faculty members — Don Cleveland, who studies fundamental cellular mechanisms in the search for new treatments for diseases like amyotrophic lateral sclerosis (ALS), and James McKernan, a mathematician who investigates algebraic geometry and multivariate polynomials — are recipients of the 2018 Breakthrough Prize, along with Joanne Chory, a plant biologist at Salk Institute for Biological Studies and adjunct professor in the Division of Biological Sciences at UC San Diego.
December 1, 2017
December 1, 2017 —
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.
November 30, 2017
November 30, 2017 —
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically distinct subpopulation of patients with glioblastoma that is particularly sensitive to drugs like cilengitide that target a cell adhesion receptor known as integrin αvβ3.
November 27, 2017
November 27, 2017 —
The University of California San Diego will recognize World AIDS Day on Friday, Dec. 1 to draw attention to the impact of HIV/AIDS has on the San Diego community, the nation and the globe. In honor of the international event, which was established in 1988, the campus will sponsor a number of free activities open to the public including a display of three sections of the AIDS Memorial Quilt, the largest ongoing arts project in the world.
November 27, 2017
November 27, 2017 —
A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years.
November 20, 2017
November 20, 2017 —
The UC San Diego Health International Patient Program was recognized as the 2017 Medical Provider of the Year by the International Travel & Health Insurance Journal (ITIJ). ITIJ recognizes leading health systems from around the globe for their ability to provide comprehensive, culturally-sensitive care to patients from international destinations.
